The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Norton Rose Fulbright US LLP

1301 AVENUE OF THE AMERICAS, NEW YORK, NY 10019-6022, USA
Tel:
Work +1 212 318 3000
Email:
Web:
www.nortonrosefulbright.com

Robin Adelstein

Tel:
Work 212 318 3108
Email:
Norton Rose Fulbright

Work Department

Life sciences and healthcare

Career

http://www.nortonrosefulbright.com/people/130285


United States: Antitrust

Civil litigation/class actions

Within: Civil litigation/class actions

Norton Rose Fulbright US LLP’s traditional strengths are in energy, healthcare, technology, entertainment (particularly disputes involving movie distribution) and transport, with clients including the likes of Phillips 66, Shell, Baylor Health Care System, and ABX Logistics. Anne Rodgers, who is based in Houston alongside practice head Layne Kruse and Darryl Anderson, was particularly active, and recent highlights for her include handling the appeal, for client American Alloy Steel, of a jury trial verdict that found that steel service centers and mills participated in a group boycott to shut down a competing steel service center. In Washington DC, Neely Agin made partner, while in New York, the group added Robin Adelstein, a life sciences expert who joined from an in-house position at Novartis.

[back to top]

United States: Dispute resolution

International litigation

Within: International litigation

Norton Rose Fulbright US LLP has recently bolstered its international litigation practice with several additions to its already talented team. Paul Keller, who focuses on patent and trade secret litigation, joined the firm’s New York office from Allen & Overy LLP in July 2015. Robin Adelstein, former counsel to the generics division of Novartis, arrived in the New York office in the same month. David Navetta and Boris Segalis, cybersecurity experts based in Denver and New York respectively, came on board in November 2014. These four joined Houston-based Gerard Pecht, the global head of dispute resolution and litigation, and Louis Strubeck, who splits his time between New York and Dallas. In a recent highlight, Bill Leone represented a former managing director in JPMorgan’s chief investment office in various proceedings brought by regulatory enforcement agencies in the US and elsewhere, including the DOJ, the SEC and the UK’s Financial Conduct Authority. The firm services global corporations such as AT&T, General Electric and Shell.

[back to top]

United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

Norton Rose Fulbright US LLP’s team advises a range of pharmaceutical, medical device and biotechnology companies, as well as investors in the life sciences sector. The practice has a solid IP litigation practice and a strong government investigations group. In a recent highlight, Michael Koon and Carol Poindexter acted on a putative nationwide class action on behalf of third-party payors alleging RICO and common law violations from the operation of GlaxoSmithKline co-pay assistance programs. Washington DC-based Frederick Robinson co-heads the global life sciences and healthcare practice, which enhanced its transactional capabilities with the arrival of Andres Liivak from Kaye Scholer LLP in May 2015 and, in July 2015, the arrival of former Sandoz general counsel Robin Adelstein. Liivak advised Novartis on a license, development and commercialization deal with XOMA in which Novartis acquired the global rights to XOMA’s anti-transforming growth factor-beta antibody program. Yvonne Puigcommunicates with clients effectively’ and is able to ‘effectively manage large, complex litigation’. All individuals are based in Austin unless otherwise stated.

[back to top]

Healthcare: service providers

Within: Healthcare: service providers

Norton Rose Fulbright US LLP handles big-ticket transactions and notable regulatory and litigation mandates. It has a huge presence in Texas, but represents healthcare providers nationwide, and recently advised the University of Arizona Health Network on its $1bn merger with Banner Health. Austin-based senior litigator Yvonne Puig is ‘excellent’, delivers ‘practical advice’ and has ‘poise under pressure’. Austin-based Jerry Bell, Dallas’ Lisa Genecov, and James Wiehl in St Louis are recommended for transactions. Washington DC’s Rick Robinson is noted for government investigations and white-collar criminal cases. The New York presence has grown through a sequence of lateral hires, including Robin Adelstein, former North American general counsel of Sandoz.

[back to top]


Back to index

Legal Developments by:
Norton Rose Fulbright

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Innovation & Thailand 4.0: Value Creation for Business using Trade Secrets

    Thailand 4.0 stands for the new stage to transform the country currently relying on heavy industries (3.0 stage) into a creativity and innovation-driven economy. Trade secrets are definitively value-based and could help pursing Thailand 4.0.
  • Novelties Introduced by the Movable Pledge Law

    As of January 1, 2017, Law No. 6750 on Pledge over Movable Assets in Commercial Transactions (“Movable Pledge Law “), which was enacted on October 20, 2016, entered into force and abolished Law No.1447 on Commercial Enterprise Pledge (“Commercial Enterprise Pledge Law “). The Movable Pledge Law introduces significant changes and offers more practical methods for establishing pledge over movable assets as explained below.
  • Determination of Injury in Anti-Dumping Investigations: Turkey’s Side of the Story

    I - Introduction
  • Tax evasion: Only voluntary disclosure affords protection from severe penalties

    Anyone who has been caught for tax evasion should expect to be faced with severe penalties. Voluntary disclosure is the only way of returning to a state of normal tax affairs and avoiding penalties.
  • Turkish Health PPP Projects

    The Turkish health sector has undergone major reforms over the past ten years as part of the health transformation program. The most important pillar of such program has been the development of public-private partnership (“PPP ”) model health campus projects. More than twenty health campus projects with an investment amount of more than € 10 billion have been developed through PPP model in Turkey. They are currently at different stages ranging from tendering to operation, and more than ten health PPP projects are still in the pipeline.
  • Infrastructure REIC: An Alternative Source of Funding for Infrastructure Projects

    With the start of operation in certain BOT and other PPP model infrastructure projects in Turkey, refinancing alternatives have become more attractive and diversified. Capital market instruments and institutions are likely to have a greater share in the refinancings of projects which have become operational and the construction risks have been removed. Over the last few years, the use of capital market instruments in the infrastructure financings have gained a new impetus with the introduction of various incentives and financing solutions in this aspect. Most recently, the removal of the 1/3 and 1/5 bond issuance limits for healthcare PPP projects on 18 February 2017 represented an important step towards incentivizing the use of bonds in the healthcare sector. In line with this overall strategy, the government has also adopted various measures to make the Real Estate Investment Companies (“REICs ”) more attractive for the financing/refinancing of infrastructure projects such as BOT, BLT and other PPP projects.
  • Ankara-Niğde Highway Project

    Tender process for 330 km Ankara-Niğde Highway Project has been launched by the General Directorate of Highways upon publication of the tender announcement in the Official Gazette on December 30, 2016.
  • Establishment of the Natural Gas Spot Market in Turkey

    In line with the government’s objectives to make Turkey a regional hub for natural gas trading, a natural gas spot market has been established by the Natural Gas Organized Wholesale Market Regulation published in the Official Gazette on 31 March 2017.
  • Philippine Court of Appeals Denies Issuance of Environmental Protection Order Against Mining Company

    In a decision issued on March 8, 2017, the Philippine Court of Appeals (CA) denied the petition by NGO Ang Aroroy ay Alagaan, Inc. and certain individuals, for the issuance of a writ of kalikasan against Filminera Resources Corporation, and its directors and officers. The petitioners have claimed that Filminera, which operates in the Philippine province of Masbate, had been causing environmental damage in the conduct of its mining operations in violation of local law, and that a writ of kalikasan should be issued.
  • LIS ALIBI PENDENS UNDER THE COUNCIL REGULATION (EC) NO 44/2001 ON JURISDICTIONAND THE RECOGNITION AN

    Lis Alibi pendens is Latin for ‘suit pending elsewhere .’ Both Articles 27 and 28 of the EU Regulation 44/2001 regulate the existence of lis alibi pendens and related judicial actions. In particular it is a doctrine that regulates the jurisdictional relationship of courts hearing concurrent proceedings involving the same or related causes of action between the same parties pending in the courts of different Member States.